Activation of these pathways in tumor cells induces the production of type I IFNs via the serine/threonine kinase TBK1 (TANK-binding kinase 1) and transcription factor IRF3 (IFN regulatory factor 3) (7–11). Here, TBK1 is linked to neoplasm.